| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-03-16 03:43:39 UTC |
|---|
| Update Date | 2023-02-21 17:30:48 UTC |
|---|
| HMDB ID | HMDB0062326 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether |
|---|
| Description | 1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether, also known as aether or anesthetic ether, belongs to the class of organic compounds known as dialkyl ethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are alkyl groups. This slows down the metabolism of ethanol and also inhibits the metabolism of other drugs requiring oxidative metabolism. 1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether is an extremely weak basic (essentially neutral) compound (based on its pKa). Outside of the human body, 1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether has been detected, but not quantified in, tea. This could make 1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether a potential biomarker for the consumption of these foods. 1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether is a potentially toxic compound. Di1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether inhibits alcohol dehydrogenase. Inhalation may result in dizziness, giddiness, euphoria, drowsiness, salivation, and CNS depression. Di1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether can be absorbed following ingestion and inhalation, and is then rapidly distributed to the brain and fatty tissues. Di1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether is not metabolized in humans and is excreted mainly in expired air. Death due to respiratory depression may result from severe and prolonged exposure. Di1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether causes CNS depression. There is no antidote for di1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether poisoning, thus treatment is symptomatic and supportive. Di1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether is also a skin and eye irritant. |
|---|
| Structure | InChI=1S/C4H10O/c1-3-5-4-2/h3-4H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 1,1'-Oxybisethane | ChEBI | | 3-Oxapentane | ChEBI | | Aether | ChEBI | | Aether pro narcosi | ChEBI | | Anesthetic ether | ChEBI | | Diethyl oxide | ChEBI | | Diethylaether | ChEBI | | Ether | ChEBI | | Ethoxyethane | ChEBI | | Ethyl ether | ChEBI | | Ethyl oxide | ChEBI | | Pronarcol | ChEBI | | R-610 | ChEBI | | Diethyl ether | Kegg | | Ether, diethyl | HMDB | | Ether, ethyl | HMDB |
|
|---|
| Chemical Formula | C4H10O |
|---|
| Average Molecular Weight | 74.1216 |
|---|
| Monoisotopic Molecular Weight | 74.073164942 |
|---|
| IUPAC Name | ethoxyethane |
|---|
| Traditional Name | diethyl ether |
|---|
| CAS Registry Number | 60-29-7 |
|---|
| SMILES | CCOCC |
|---|
| InChI Identifier | InChI=1S/C4H10O/c1-3-5-4-2/h3-4H2,1-2H3 |
|---|
| InChI Key | RTZKZFJDLAIYFH-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dialkyl ethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are alkyl groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Ethers |
|---|
| Direct Parent | Dialkyl ethers |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dialkyl ether
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 39 g/l | ALOGPS | | LogP | 1.12 | ALOGPS |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter)). Predicted by Afia on May 17, 2022. | 2.57 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.9651 minutes | 33406817 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1520.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 506.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 189.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 345.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 125.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 467.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 526.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 204.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 989.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 336.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1128.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 387.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 303.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 515.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 501.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 96.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether | CCOCC | 600.5 | Standard polar | 33892256 | | 1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether | CCOCC | 485.1 | Standard non polar | 33892256 | | 1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether | CCOCC | 469.4 | Semi standard non polar | 33892256 |
|
|---|